placeNew Zealand

Connect with every touch.

For your most critical neonatal and adult patients, every touch has an impact on their well-being. Continuous monitoring devices should minimise impact and maximise performance. So, we designed our enhanced Nellcor™ OxySoft™ SpO2 sensor to perform better in low perfusion and thick tissue, stay on longer, and be repositioned without pulling on or damaging fragile skin.†‡ With brighter LEDs, a new silicone adhesive and a lower profile, it’s a lighter touch on your patients — allowing you more time to connect.

Nellcor™ OxySoft™ SpO2 sensor brochure and specification sheet

Download brochure to learn more.

View Brochure


For your most vulnerable patients.

Introducing the Nellcor™ OxySoft™ SpO2 sensor. Designed with your most critical patients in mind.


Fragile skin
deserves protection.

A new silicone adhesive, lower profile, and flexible circuit on the Nellcor™ OxySoft™ SpO2 sensor:

  • Removes 87% less skin cells from fragile skin† 
  • Stays in place longer, even through motion


Quick decisions
need fast readings.

Brighter LEDs and thoughtful cord placement on the Nellcor™ OxySoft™ SpO2 sensor help with: 

  • 50% better signal acquisition and 50% reduction in time to post in simulated low perfusion and thicker tissue 
  • Managing motion interference


Busy days
demand efficiency.

Spend less time on sensors losing adhesiveness or getting stuck together. The Nellcor™ OxySoft™ SpO2 sensor:

  • Is easy to peel apart and reposition§
  • Withstands up to 18 repositions† 
  • Helps you use less and get more time back in your day


Easy to apply

Sensor graphics and new silicone adhesive make the Nellcor™ OxySoft™ SpO2 sensor easy and efficient to apply. Watch this video on how to apply to adult patients, and download our application guides for both neonatal and adult patients.*

Download neonatal application guide
Download adult application guide

  • The Nellcor™ pulse oximetry monitoring system should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment.

  • *Please update with our standard IFU statement: "Please refer to the Instructions for Use for a complete list of indications, contraindications, warnings, precautions and other important medical information. Always read and follow the Instructions for Use.

  • †Based on validation data in head-to-head clinical testing compared to MaxN CSR 2021 0312v1 S20-12.

  • ‡During internal head-to-head bench test compared to MaxN with validated test equipment.

  • §Based on a hands-on evaluation with clinicians.